Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug ...

The MDL was set to head to trial May 19 and involves Jazz along with generic drug maker Hikma Pharmaceutical, which was granted permission to launch the first Xyrem copycat in early 2023.

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to patents for its narcolepsy drug, Sunosi (solriamfetol). The settlement ...

Hikma Pharmaceuticals PLC announces an exclusive licensing agreement with pharmaand GmbH to commercialise rucaparib across the Middle East and North Africa (Petra photo) AMMAN — Hikma Pharmaceuticals ...

Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected opioid overdose, as manifested by respiratory and/or ...

LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ...

British stocks ended lower on Wednesday, dragged by heavyweight pharmaceutical stocks, while markets remained focused on tariff escalations between the U.S. and China. April 8, 2025 Jazz Pharma to ...

Hikma’s US subsidiary, West-Ward Pharmaceuticals, formerly Boehringer Ingelheim’s US generic business, Roxane, will be responsible for development. Vectura will complete the formulation ...